Open AccessIntravenous glucocorticoids therapy in the treatment of Graves’ ophthalmopathy: a systematic review and Meta-analysis
Author(s) -
Li-Quan Zhao
Publication year - 2019
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2019.07.20
Subject(s) - medicine , meta analysis , placebo , confidence interval , relative risk , randomized controlled trial , adverse effect , graves' ophthalmopathy , rituximab , systematic review , medline , physical therapy , graves' disease , alternative medicine , disease , pathology , political science , law , lymphoma
To evaluate the benefit and harms of high-dose intravenous glucocorticoids (IVGC) as first-line treatment for Graves' ophthalmopathy (GO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom